{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:20:33Z","timestamp":1772234433278,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12325-020-01275-4","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T18:03:21Z","timestamp":1588701801000},"page":"2884-2901","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Qualitative Interviews to Better Understand the Patient Experience and Evaluate Patient-Reported Outcomes (PRO) in RLBP1 Retinitis Pigmentosa (RLBP1 RP)"],"prefix":"10.1007","volume":"37","author":[{"given":"Jane","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Burstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Holopigian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kali","family":"Stasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Sloesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Spera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Deslandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmol","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"1275_CR1","volume-title":"NICE Citizens Council Report: ultra orphan drugs","author":"NC Council","year":"2004","unstructured":"Council NC. NICE Citizens Council Report: ultra orphan drugs. London: National Institute for Health and Clinical Excellence; 2004."},{"issue":"2","key":"1275_CR2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(99)00060-4","volume":"128","author":"PJ Botelho","year":"1999","unstructured":"Botelho PJ, Blinder KJ, Shahinfar S. Familial occurrence of retinitis punctata albescens and congenital sensorineural deafness. Am J Ophthalmol. 1999;128(2):246\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1275_CR3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajo.2004.02.060","volume":"138","author":"FYK Demirci","year":"2004","unstructured":"Demirci FYK, Rigatti BW, Mah TS, Gorin MB. A novel compound heterozygous mutation in the cellular retinaldehyde-binding protein gene (RLBP1) in a patient with retinitis punctata albescens. Am J Ophthalmol. 2004;138(1):171\u20133.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1275_CR4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamaophthalmol.2013.4476","volume":"131","author":"E Dessalces","year":"2013","unstructured":"Dessalces E, Bocquet B, Bourien J, Zanlonghi X, Verdet R, Meunier I, et al. Early-onset foveal involvement in retinitis punctata albescens with mutations in RLBP1. JAMA Ophthalmol. 2013;131(10):1314\u201323.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"1275_CR5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/339688","volume":"70","author":"ER Eichers","year":"2002","unstructured":"Eichers ER, Green JS, Stockton DW, Jackman CS, Whelan J, McNamara JA, et al. Newfoundland rod-cone dystrophy, an early-onset retinal dystrophy, is caused by splice-junction mutations in RLBP1. Am J Hum Genet. 2002;70(4):955\u201364.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1275_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archopht.122.1.70","volume":"122","author":"GA Fishman","year":"2004","unstructured":"Fishman GA, Roberts MF, Derlacki DJ, Grimsby JL, Yamamoto H, Sharon D, et al. Novel mutations in the cellular retinaldehyde-binding protein gene (RLBP1) associated with retinitis punctata albescens. Arch Ophthalmol. 2004;122(1):70\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1275_CR7","first-page":"571","volume":"70","author":"M Flynn","year":"1999","unstructured":"Flynn M, Bohnert D. Fundus albipunctatus and other flecked retina syndromes. J Am Optom Assoc. 1999;70(9):571\u201380.","journal-title":"J Am Optom Assoc"},{"issue":"2","key":"1275_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/13816810903584971","volume":"31","author":"MA Genead","year":"2010","unstructured":"Genead MA, Fishman GA, Lindeman M. Spectral-domain optical coherence tomography and fundus autofluorescence characteristics in patients with fundus albipunctatus and retinitis punctata albescens. Ophthalmic Genet. 2010;31(2):66\u201372.","journal-title":"Ophthalmic Genet"},{"issue":"4","key":"1275_CR9","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1111\/aos.12573","volume":"93","author":"S Hipp","year":"2015","unstructured":"Hipp S, Zobor G, Gl\u00f6ckle N, Mohr J, Kohl S, Zrenner E, et al. Phenotype variations of retinal dystrophies caused by mutations in the RLBP1 gene. Acta Ophthalmol. 2015;93(4):e281\u20136.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"1275_CR10","first-page":"299","volume":"22","author":"X Zhang","year":"2004","unstructured":"Zhang X, Wen F, Hu S, Yan H, Lin S. Fundus angiography findings of atypical retinitis pigmentosa. Chin Ophthalmic Res. 2004;22(3):299\u2013301.","journal-title":"Chin Ophthalmic Res"},{"issue":"11","key":"1275_CR11","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1167\/iovs.05-1488","volume":"47","author":"G Humbert","year":"2006","unstructured":"Humbert G, Delettre C, S\u00e9n\u00e9chal A, Bazalgette C, Barakat A, Bazalgette C, et al. Homozygous deletion related to Alu repeats in RLBP1 causes retinitis punctata albescens. Investig Ophthalmol Vis Sci. 2006;47(11):4719\u201324.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"1275_CR12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1034\/j.1399-0004.2001.590607.x","volume":"59","author":"N Katsanis","year":"2001","unstructured":"Katsanis N, Shroyer N, Lewis R, Cavender J, Al-Rajhi A, Jabak M, et al. Fundus albipunctatus and retinitis punctata albescens in a pedigree with an R150Q mutation in RLBP1. Clin Genet. 2001;59(6):424\u20139.","journal-title":"Clin Genet"},{"issue":"2","key":"1275_CR13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1097-198","volume":"17","author":"MA Maw","year":"1997","unstructured":"Maw MA, Kennedy B, Knight A, Bridges R, Roth KE, Mani E, et al. Mutation of the gene encoding cellular retinaldehyde\u2013binding protein in autosomal recessive retinitis pigmentosa. Nat Genet. 1997;17(2):198\u2013200.","journal-title":"Nat Genet"},{"issue":"5","key":"1275_CR14","first-page":"1000","volume":"40","author":"H Morimura","year":"1999","unstructured":"Morimura H, Berson EL, Dryja TP. Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding protein in a form of retinitis punctata albescens. Investig Ophthalmol Vis Sci. 1999;40(5):1000\u20134.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"1275_CR15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ajo.2004.12.011","volume":"139","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Lin J, Ito Y, Miyake Y. Novel mutation in RLBP1 gene in a Japanese patient with retinitis punctata albescens. Am J Ophthalmol. 2005;139(6):1133\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"1275_CR16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bjo.2010.189076","volume":"95","author":"S Naz","year":"2011","unstructured":"Naz S, Ali S, Riazuddin SA, Farooq T, Butt NH, Zafar AU, Khan SN, Husnain T, MacDonald IM, Sieving PA, Hejtmancik JF. Mutations in RLBP1 associated with fundus albipunctatus in consanguineous Pakistani families. Br J Ophthalmol. 2011;95(7):1019\u201324.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1275_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/13816810.2011.634877","volume":"33","author":"K Nojima","year":"2012","unstructured":"Nojima K, Hosono K, Zhao Y, Toshiba T, Hikoya A, Asai T, et al. Clinical features of a Japanese case with Bothnia dystrophy. Ophthalmic Genet. 2012;33(2):83\u20138.","journal-title":"Ophthalmic Genet"},{"key":"1275_CR18","unstructured":"van Genderen MM, Littink KW, van Schooneveld, MJ, Riemslag FCC, Keunen JEE, den Hollander AI, et al. Genotypes and phentotypes in fundus albipunctatus and retinitis punctata albescens [abstract]. In: Proceedings of the 50th ISCEV International Symposium; 5\u20138 June 2012; Valencia, Spain. Abstract number OS2-4."},{"issue":"9549","key":"1275_CR19","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795\u2013809.","journal-title":"Lancet"},{"issue":"5","key":"1275_CR20","first-page":"995","volume":"40","author":"M Burstedt","year":"1999","unstructured":"Burstedt M, Sandgren O, Holmgren G, Forsman-Semb K. Bothnia dystrophy caused by mutations in the cellular retinaldehyde-binding protein gene (RLBP1) on chromosome 15q26. Investig Ophthalmol Vis Sci. 1999;40(5):995\u20131000.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1275_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-540-69466-3_11","volume-title":"Retinitis punctata albescens. Inherited chorioretinal dystrophies","author":"C Hamel","year":"2014","unstructured":"Hamel C, Dessalces E, Meunier I. Retinitis punctata albescens. Inherited chorioretinal dystrophies. Berlin: Springer; 2014. p. 135\u201341."},{"key":"1275_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/OPTH.S8713","volume":"4","author":"MS Burstedt","year":"2010","unstructured":"Burstedt MS, M\u00f6nestam E. Self-reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia type. Clin Ophthalmol (Auckland, NZ). 2010;4:147.","journal-title":"Clin Ophthalmol (Auckland, NZ)."},{"issue":"8","key":"1275_CR23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch KE, Marquis P, Vigneux M, Abetz L, Arnould B, Bayliss M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010;19(8):1087\u201396.","journal-title":"Qual Life Res"},{"key":"1275_CR24","unstructured":"US Department of Health and Human Services. Food and Drug Administration. 2009. Guidance for Industry: Patient-reported outcome measures: use in medical product development to support labeling claims. http:\/\/www.da.gov\/downloads\/drugs\/guidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf. Accessed December 5, 2012."},{"issue":"7","key":"1275_CR25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-list-item national eye institute visual function questionnaire. Arch Ophthalmol. 2001;119(7):1050\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"1275_CR26","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","volume":"116","author":"CM Mangione","year":"1998","unstructured":"Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute visual function questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116(11):1496\u2013504.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"1275_CR27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1167\/iovs.05-1222","volume":"47","author":"C Owsley","year":"2006","unstructured":"Owsley C, McGwin G, Scilley K, Kallies K. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. Investig Ophthalmol Vis Sci. 2006;47(2):528\u201335.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1275_CR28","first-page":"26","volume":"1","author":"M Sloane","year":"1992","unstructured":"Sloane M, Ball K, Owsley C, Bruni J, Roenker D. The Visual Activities Questionnaire: developing an instrument for assessing problems in everyday visual tasks. Tech Dig Noninvasive Assess Vis Syst. 1992;1:26\u20139.","journal-title":"Tech Dig Noninvasive Assess Vis Syst"},{"issue":"3","key":"1275_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00006982-200504000-00011","volume":"25","author":"MS Burstedt","year":"2005","unstructured":"Burstedt MS, M\u00f6nestam E, Sandgren O. Associations between specific measures of vision and vision-related quality of life in patients with bothnia dystrophy, a defined type of retinitis pigmentosa. Retina. 2005;25(3):317\u201323.","journal-title":"Retina."},{"issue":"8","key":"1275_CR30","first-page":"3251","volume":"58","author":"A Mullins","year":"2017","unstructured":"Mullins A, Burstedt M, Green J, Whelan J, Sloesen B, Ni X, et al. Cross-sectional evaluation of patient-reported outcomes (PROs) in patients with RLBP1 retinitis pigmentosa enrolled in a Natural History Study. Investig Ophthalmol Vis Sci. 2017;58(8):3251.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"10","key":"1275_CR31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/08870440903194015","volume":"25","author":"JJ Francis","year":"2010","unstructured":"Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, et al. What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health. 2010;25(10):1229\u201345.","journal-title":"Psychol Health."},{"issue":"1","key":"1275_CR32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods."},{"issue":"4","key":"1275_CR33","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1167\/iovs.14-16237","volume":"56","author":"K Latham","year":"2015","unstructured":"Latham K, Baranian M, Timmis MA, Pardhan S. Difficulties with goals of the Dutch ICF activity inventory: perceptions of those with retinitis pigmentosa and of those who support them. Investig Ophthalmol Vis Sci. 2015;56(4):2381\u201391.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"1275_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"9","key":"1275_CR35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res"},{"issue":"3","key":"1275_CR36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/erp.10.30","volume":"10","author":"C Kerr","year":"2010","unstructured":"Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):269\u201381.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"1275_CR37","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2\u2014assessing respondent understanding. Value Health. 2011;14(8):978\u201388.","journal-title":"Value Health."},{"key":"1275_CR38","unstructured":"World Health Organisation. Change the definition of blindness. https:\/\/www.who.int\/blindness\/Change%20the%20Definition%20of%20Blindness.pdf. Accessed Dec 5, 2012."},{"issue":"3","key":"1275_CR39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5005\/jp-journals-10008-1186","volume":"9","author":"MC Sousa","year":"2015","unstructured":"Sousa MC, Biteli LG, Dorairaj S, Maslin JS, Leite MT, Prata TS. Suitability of the visual field index according to glaucoma severity. J Curr Glaucoma Pract. 2015;9(3):65.","journal-title":"J Curr Glaucoma Pract"},{"issue":"1","key":"1275_CR40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-1-40","volume":"1","author":"C Hamel","year":"2006","unstructured":"Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1(1):40.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"1275_CR41","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/hmg\/11.10.1219","volume":"11","author":"C Rivolta","year":"2002","unstructured":"Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet. 2002;11(10):1219\u201327.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1275_CR42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006324-199203000-00003","volume":"69","author":"J Lowe","year":"1992","unstructured":"Lowe J, Drasdo N. Patients\u2019 responses to retinitis pigmentosa. Optom Vis Sci. 1992;69(3):182\u20135.","journal-title":"Optom Vis Sci"},{"issue":"5","key":"1275_CR43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/eye.2016.315","volume":"31","author":"MP Senthil","year":"2017","unstructured":"Senthil MP, Khadka J, Pesudovs K. Seeing through their eyes: lived experiences of people with retinitis pigmentosa. Eye. 2017;31(5):741.","journal-title":"Eye."},{"issue":"4","key":"1275_CR44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/eye.2009.176","volume":"24","author":"T Sugawara","year":"2010","unstructured":"Sugawara T, Hagiwara A, Hiramatsu A, Ogata K, Mitamura Y, Yamamoto S. Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa. Eye. 2010;24(4):535.","journal-title":"Eye."},{"issue":"11","key":"1275_CR45","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1167\/iovs.11-7858","volume":"52","author":"RP Finger","year":"2011","unstructured":"Finger RP, Fenwick E, Owsley C, Holz FG, Lamoureux EL. Visual functioning and quality of life under low luminance: evaluation of the German Low Luminance Questionnaire. Investig Ophthalmol Vis Sci. 2011;52(11):8241\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1275_CR46","first-page":"753","volume":"96","author":"RP Mills","year":"1998","unstructured":"Mills RP. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophthalmol Soc. 1998;96:753.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"1275_CR47","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jcrs.2009.05.058","volume":"35","author":"VK Gothwal","year":"2009","unstructured":"Gothwal VK, Wright TA, Lamoureux EL, Pesudovs K. Visual Activities Questionnaire: assessment of subscale validity for cataract surgery outcomes. J Cataract Refract Surg. 2009;35(11):1961\u20139.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"1275_CR48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajo.2008.08.011","volume":"147","author":"RD Levinson","year":"2009","unstructured":"Levinson RD, Monnet D, Yu F, Holland GN, Gutierrez P, Brezin AP. Longitudinal cohort study of patients with birdshot chorioretinopathy. V. Quality of life at baseline. Am J Ophthalmol. 2009;147(2):346\u201350.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1275_CR49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ceo.13022","volume":"46","author":"DC Chung","year":"2018","unstructured":"Chung DC, McCague S, Yu ZF, Thill S, DiStefano-Pappas J, Bennett J, Cross D, Marshall K, Wellman J, High KA. Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clin Exp Ophthalmol. 2018;46(3):247\u201359.","journal-title":"Clin Exp Ophthalmol"},{"issue":"10097","key":"1275_CR50","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA, Chung DC, Yu Z-F, Tillman A, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390(10097):849\u201360.","journal-title":"Lancet."},{"issue":"8","key":"1275_CR51","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/OPX.0000000000000001","volume":"90","author":"J Khadka","year":"2013","unstructured":"Khadka J, McAlinden C, Pesudovs K. Quality assessment of ophthalmic questionnaires: review and recommendations. Optom Vis Sci. 2013;90(8):720\u201344.","journal-title":"Optom Vis Sci"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01275-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01275-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01275-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T18:32:13Z","timestamp":1696098733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01275-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1275"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01275-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}